Star Imaging And Path Lab Ltd vs Syngene International Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Star Imaging and Path Lab Ltd is ₹ 74.7 as of 23 Oct 15:30 . The P/E Ratio of Star Imaging and Path Lab Ltd changed from 4.2 on March 2026 to 4.2 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 years The Market Cap of Star Imaging and Path Lab Ltd changed from ₹ 80.64 crore on March 2026 to ₹ 80.64 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 years The revenue of Star Imaging and Path Lab Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Syngene International Ltd for the Jun '26 is ₹ 761.3 crore as compare to the Mar '26 revenue of ₹ 1058 crore. This represent the decline of -28.09% The ebitda of Star Imaging and Path Lab Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Syngene International Ltd for the Jun '26 is ₹ 102.6 crore as compare to the Mar '26 ebitda of ₹ 319.6 crore. This represent the decline of -67.9% The net profit of Star Imaging and Path Lab Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ -9 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Star Imaging and Path Lab Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 years .

About Star Imaging and Path Lab Ltd

Star Imaging and Path Lab Limited was originally incorporated as a private limited Company as 'Star Imaging & Path Lab Private Limited' dated May 31, 2004, issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana.
Subsequently, it converted into a Public Company and the name of the Company was changed to 'Star Imaging and Path Lab Limited' on September 17, 2024 issued by Central Processing Centre. The Company started its journey from 1978 as proprietorship under the name of Janta X-Ray Clinic and were providing X-ray and basic pathology tests using manual methods.
Over the years, they have upgraded their services, equipment, and diagnostic technologies to incorporate latest advancements in medical science, ensuring the care and improved patient outcomes.
This vision led to establishment of Star Imaging & Path Lab Private Limited in 2004, as Private Limited entity, to offer pathology, radiology, Cardiology, and Neurology services under one roof.

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

FAQs for the comparison of Star Imaging and Path Lab Ltd and Syngene International Ltd

Which company has a larger market capitalization, Star Imaging and Path Lab Ltd or Syngene International Ltd?

Market cap of Star Imaging and Path Lab Ltd is 130 Cr while Market cap of Syngene International Ltd is 14,810 Cr

What are the key factors driving the stock performance of Star Imaging and Path Lab Ltd and Syngene International Ltd?

The stock performance of Star Imaging and Path Lab Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Star Imaging and Path Lab Ltd and Syngene International Ltd?

As of October 24, 2026, the Star Imaging and Path Lab Ltd stock price is INR ₹74.7. On the other hand, Syngene International Ltd stock price is INR ₹366.9.

How do dividend payouts of Star Imaging and Path Lab Ltd and Syngene International Ltd compare?

To compare the dividend payouts of Star Imaging and Path Lab Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.